Advances in nanocarriers for effective delivery of docetaxel in the treatment of lung cancer: an overview

SA A. Razak, A Mohd Gazzali, FA Fisol, I M. Abdulbaqi… - Cancers, 2021 - mdpi.com
Simple Summary As lung cancer has the highest incidence rate compared to any other type
of cancer, there have been extensive research studies aiming at finding a better treatment …

Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends

MF Sohail, M Rehman, HS Sarwar… - International journal …, 2018 - Taylor & Francis
The oral delivery of cancer chemotherapeutic drugs is challenging due to low bioavailability,
gastrointestinal side effects, first-pass metabolism and P-glycoprotein efflux pumps. Thus …

How nanotechnology can enhance docetaxel therapy

L Zhang, N Zhang - International journal of nanomedicine, 2013 - Taylor & Francis
Docetaxel has been recognized as one of the most efficient anticancer drugs over the past
decade; however, its poor water solubility and systemic toxicity have greatly limited its …

Advanced cisplatin nanoformulations as targeted drug delivery platforms for lung carcinoma treatment: A review

SR Pavan, A Prabhu - Journal of Materials Science, 2022 - Springer
Lung cancer accounts for the second-highest death rate globally among cancer-associated
mortality. Cisplatin is a first-line chemotherapy medication used for the treatment of lung …

Nanoparticles loaded with docetaxel and resveratrol as an advanced tool for cancer therapy

M Jurczyk, J Kasperczyk, D Wrześniok, A Beberok… - Biomedicines, 2022 - mdpi.com
A growing interest in the use of a combination of chemosensitizers and cytostatics for
overcoming cancer resistance to treatment and the development of their delivery systems …

A comprehensive review of current perspectives on novel drug Delivery systems and approaches for lung cancer management

U Hani, S Wahab, A Siddiqua, RAM Osmani… - Journal of …, 2021 - Springer
Cancer is one of the fatal diseases that cause many deaths around the world. Lung cancer
has the highest incidence and mortality rates among cancer-related death worldwide. Lung …

Preparation, optimization, and in vivo evaluation of nanoparticle-based formulation for pulmonary delivery of anticancer drug

N Chishti, S Jagwani, D Dhamecha, S Jalalpure… - Medicina, 2019 - mdpi.com
Background and Oobjectives: Lung cancer, a pressing issue in present-day society due to its
high prevalence and mortality rate, can be managed effectively by long-term delivery of …

Docetaxel-loaded novel nano-platform for synergistic therapy of non-small cell lung cancer

X Feng, X Xiong, S Ma - Frontiers in Pharmacology, 2022 - frontiersin.org
Nowadays, non-small cell lung cancer (NSCLC) is threatening the health of all mankind.
Although many progresses on treatment of lung cancer have been achieved in the past few …

Emerging trends in the novel drug delivery approaches for the treatment of lung cancer

P Sharma, M Mehta, DS Dhanjal, S Kaur… - Chemico-biological …, 2019 - Elsevier
Cancer is one of the major diseases that cause a high number of deaths globally. Of the
major types of cancers, lung cancer is known to be the most chronic form of cancer in the …

Docetaxel: An update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer

M Imran, S Saleem, A Chaudhuri, J Ali… - Journal of Drug Delivery …, 2020 - Elsevier
Amongst the various microtubule-targeting agents, Docetaxel (DTX) has gained immense
attention in cancer chemotherapy due to its good therapeutic index. DTX belongs to the …